Concepedia

Publication | Closed Access

Role of gemcitabine as second-line therapy after progression on FOLFIRINOX in advanced pancreatic cancer: a retrospective analysis.

DOI

29

Citations

8

References

2015

Year

Aline da Rocha Lino, Carina Meira Abrahão, Raphael Moreira Brandão, Jéssica Ribeiro Gomes, Andrea Malta Ferrian, Marcel Cerqueira César Machado, Antônio C. Buzaid, Fernando Cotait Maluf, Renata D’Alpino Peixoto
PubMed

Abstract

In this study, gemcitabine was a reasonable second-line treatment option for patients with advanced pancreatic adenocarcinoma and good ECOG performance status. Phase III trials are urgently needed comparing gemcitabine versus best supportive of care (BSC) can evaluate the real benefit of this chemotherapy after progression on FOLFIRINOX.

References

YearCitations

Page 1